This webinar will examine the 15 sub parts of the Medical Device CGMPs, 21 CFR 820, the Quality System Regulation, compared against the current version of ISO 13485:2016, with its 8 "sub parts". The substantial areas of similarities will be discusses; then the areas of FDA concern and proposed solutions; and the adding in those requirements necessary to remain in alignment with the US FDA's Federal Food, Drug & Cosmetic Act.
The structure of the proposed QMSR will be discussed: 820.1 Scope; 820.3 Definitions; 820.7 Incorporation (ISO 13485:2016) by reference; 820.10 Requirements for a quality management system - Links additional FDA requirements such as MDR, UDI, Corrections & Removals, and Tracking; applicability of Design and Development activities; 820.15 Clarification of concepts - Correlates concepts in ISO 13485 to FDA; 820.35 Control of records - Supplements record keeping activities, signature and date, complaint / servicing records, UDI, and confidentiality; and 820.45 Device labeling and packaging controls. The primary areas of differences: Document Control, Labeling and Packaging Control, Records, and Servicing. These will be discussed in the webinar as well. There will be a one-year transition period.
Why Should You Attend:
FDA/CDRH is proposing to harmonize the current Quality System (QS) regulation for medical devices (21 CFR 820) by converging its requirements with requirements used by many other regulatory authorities. Revisions to Part 820 will replace most of the existing regulation with an incorporation by reference (IBR) to the 2016 edition of" ISO 13485 - Medical Devices - Quality Management Systems Requirements for Regulatory Purposes". The requirements in ISO 13485:2016 are substantially similar to the current requirements of Part 820, the QSR. Differences will be explained or reconciled, and the few areas where ISO 13485 is considered weak by the FDA will be strengthened in the proposed US QMSR.
Areas Covered in the Webinar:
Who Will Benefit:
John E. Lincoln, is Principal of J. E. Lincoln and Associates LLC, a consulting company with over 41 years experience in U.S. FDA-regulated industries, 27 years as head of his own consulting company. John has worked with companies from start-up to Fortune 100, in the U.S., Mexico, Canada, France, Germany, Sweden, China and Taiwan. He specializes in quality assurance, regulatory affairs, QMS problem remediation and FDA responses, new / changed product 510(k)s, process / product / equipment including QMS and software validations, ISO 14971 product risk management files / reports, Design Control / Design History Files, Technical Files. He's held positions in Manufacturing Engineering, QA, QAE, Regulatory Affairs, to the level of Director and VP (R&D). In addition, John has prior experience in military, government, electronics, and aerospace. He has published numerous articles in peer reviewed journals, 5 chapters in the RAPS textbook on validation, conducted workshops and webinars worldwide on CGMP subjects. John is a graduate of UCLA.
Our refund policy is governed by individual products and services refund policy mentioned against each of offerings. However in absence of specific refund policy of an offering below refund policy will be effective.
Registrants may cancel up to two working days prior to the course start date and will receive a letter of credit to be used towards a future course up to one year from date of issuance. ComplianceOnline would process/provide refund if the Live Webinar has been cancelled. The attendee could choose between the recorded version of the webinar or refund for any cancelled webinar. Refunds will not be given to participants who do not show up for the webinar. On-Demand Recordings can be requested in exchange. Webinar may be cancelled due to lack of enrolment or unavoidable factors. Registrants will be notified 24hours in advance if a cancellation occurs. Substitutions can happen any time. On-Demand Recording purchases will not be refunded as it is available for immediate streaming. However if you are not able to view the webinar or you have any concern about the content of the webinar please contact us at below email or by call mentioning your feedback for resolution of the matter. We respect feedback/opinions of our customers which enables us to improve our products and services. To contact us please email [email protected] call +1-888-717-2436 (Toll Free).
PAYMENT METHOD: 100% Secure Transaction